The correlation between the proportion of patients with pancreatic ductal adenocarcinoma who received neoadjuvant therapy and overall survival between 2004 and 2015.

被引：1

作者：

Molina, George ^{[1
]}

Chawla, Akhil ^{[1
]}

Clancy, Thomas E. ^{[1
]}

Wang, Jiping ^{[1
]}

机构：

[1] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期

关键词：

D O I：

10.1200/JCO.2019.37.4_suppl.395

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

395

引用

页数：1

共 50 条

[31] Survival outcomes of conversion surgery for metastatic pancreatic ductal adenocarcinoma after neoadjuvant therapy
Zhu, Lingyu
Gao, Suizhi
Wu, Xinqian
Li, Bo
Shi, Xiaohan
Yin, Xiaoyi
Wang, Huan
Shi, Meilong
Li, Penghao
Li, Yikai
Zhong, Chaoliang
Teng, Chuanqi
Han, Jiawei
Ren, Yiwei
Wang, Jian
Fu, Zhendong
Liu, Xinyu
Zheng, Kailian
Guo, Shiwei
Jin, Gang
JOURNAL OF PANCREATOLOGY, 2023, 6 (03) : 110 - 118
[32] Survival outcomes of conversion surgery for metastatic pancreatic ductal adenocarcinoma after neoadjuvant therapy
Zhu Lingyu
Gao Suizhi
Wu Xinqian
Li Bo
Shi Xiaohan
Yin Xiaoyi
Wang Huan
Shi Meilong
Li Penghao
Li Yikai
Zhong Chaoliang
Teng Chuanqi
Han Jiawei
Ren Yiwei
Wang Jian
Fu Zhendong
Liu Xinyu
Zheng Kailian
Guo Shiwei
Jin Gang
胰腺病学杂志（英文）, 2023, 06 (03)
[33] Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy
Liang, Tom Z.
Katz, Matthew H. G.
Prakash, Laura R.
Chatterjee, Deyali
Wang, Hua
Kim, Michael
Tzeng, Ching-Wei D.
Ikoma, Naruhiko
Wolff, Robert A.
Zhao, Dan
Koay, Eugene J.
Maitra, Anirban
Kundu, Suprateek
Wang, Huamin
CANCERS, 2023, 15 (12)
[34] Total neoadjuvant therapy is associated with improved overall survival and pathologic response in pancreatic adenocarcinoma
Villano, Anthony M.
O'Halloran, Eileen
Goel, Neha
Ruth, Karen
Barrak, Dany
Lefton, Max
Reddy, Sanjay S.
JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (03) : 502 - 512
[35] UTILIZATION OF NEOADJUVANT THERAPY IN ELDERLY PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: AN NCDB STUDY
Riachi, Mansour E.
Kaslow, Sarah R.
Jrewal, Mahip
Sorrentino, Anthony
Hewitt, Daniel B.
Winner, Megan
Cohen, Steven M.
Kaplan, Brian J.
Allendorf, John
Simeone, Diane M.
Welling, Theodore H.
Wolfgang, Christopher L.
Sacks, Greg D.
Javed, Ammar A.
GASTROENTEROLOGY, 2023, 164 (06) : S1445 - S1445
[36] Real-world overall survival and time to next treatment in patients with metastatic pancreatic ductal adenocarcinoma who received FOLFIRINOX and modified FOLFIRINOX in the first line.
Dennen, Syvart
Boppudi Naga, Sai Sriteja
Cockrum, Paul
Paluri, Ravi Kumar
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 629 - 629
[37] Use of angiotensin system inhibitors is associated with longer overall survival in pancreatic ductal adenocarcinoma patients who underwent pancreatectomy
Liu, Hao
Pinter, Matthias
Incio, Joao
Lee, Hang
Ho, William
Crain, Jonathan
Naxerova, Kamila
Di, Mengyang
Jacobson, Alex
Santos, Daniella Dias
Zanconato, Andrea
Deshpande, Vikram
Lillemoe, Keith
del Castillos, Carlos Fernandez
Downes, Michael
Evans, Ronald
Michaelson, James
Ferrone, Cristina
Boucher, Yves
Rakesh, Jain K.
CANCER RESEARCH, 2017, 77
[38] Area deprivation and rurality impact overall survival and adjuvant therapy administration in patients with pancreatic ductal adenocarcinoma (PDAC)
Pothuri, Vikram
Rodriguez, Jorge G. Zarate
Kasting, Christina
Leigh, Natasha
Hawkins, William G.
Sanford, Dominic E.
Fields, Ryan C.
HPB, 2023, 25 (12) : 1545 - 1554
[39] Correlation Between the Tumor Budding and Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
Sun, Lei
Nguyen, Joshua
Yin, Feng
LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1678 - 1678
[40] Correlation Between the Tumor Budding and Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
Sun, Lei
Nguyen, Joshua
Yin, Feng
MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1678 - 1678

← 1 2 3 4 5 →